IGKV1D-35: A Potential Drug Target and Biomarker (G28895)

Target Name: IGKV1D-35

NCBI ID: G28895

Other Name(s): O6 | immunoglobulin kappa variable 1D-35 (pseudogene) | Immunoglobulin kappa variable 1D-35 (pseudogene) | IGKV1D35

IGKV1D-35: A Potential Drug Target and Biomarker

IGKV1D-35 (O6) is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and liver. It is a member of the Integrin alpha-2 (IAAG) family, which is a group of transmembrane proteins that play a role in cell-cell adhesion, migration, and invasion.

One of the unique features of IGKV1D-35 is its ability to interact with several different cell surface molecules, including cadherins, E-cadherins, and vimentin. This interactivity makes IGKV1D-35 an interesting candidate for drug targeting, as it may be able to interact with a variety of different proteins and contribute to the development of various diseases.

One of the potential benefits of targeting IGKV1D-35 is its potential to treat a variety of different diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, IGKV1D-35 has been shown to interact with several different proteins that are involved in the development and progression of cancer, including T cells, N cells, and K cells. This suggests that targeting IGKV1D-35 may be a useful way to treat a range of different cancers.

In addition to its potential as a drug target, IGKV1D-35 is also a potential biomarker for a variety of different diseases. For example, IGKV1D-35 has been shown to be expressed in the brains of individuals with Alzheimer's disease, which suggests that it may be a useful biomarker for this disease. Additionally, IGKV1D-35 has been shown to be involved in the development and progression of a variety of neurodegenerative diseases, including Parkinson's disease and Huntington's disease. This suggests that IGKV1D-35 may be a useful biomarker for these diseases as well.

Another potential application of IGKV1D-35 is its role in cell migration and invasion. IGKV1D-35 has been shown to play a role in the migration and invasion of a variety of different cell types, including cancer cells. This suggests that targeting IGKV1D-35 may be a useful way to treat a variety of different diseases that involve the manipulation of cell migration and invasion, such as cancer.

In conclusion, IGKV1D-35 is a protein that has been shown to interact with several different cell surface molecules and may be a potential drug target or biomarker for a variety of different diseases. Further research is needed to fully understand its role in the development and progression of various diseases, and to determine its potential as a therapeutic agent.

Protein Name: Immunoglobulin Kappa Variable 1D-35 (pseudogene)

More Common Targets